MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
PerkinElmer Shares 2011-2026 | PKI
Annual Shares PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 M | 123 M | 125 M | 116 M | 112 M | - | 111 M | 110 M | 109 M | 113 M | - | 113 M | 112 M | 113 M | 331 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 331 M | 109 M | 131 M |
Quarterly Shares PerkinElmer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115 M | 118 M | 120 M | 121 M | 123 M | 123 M | 123 M | 123 M | 124 M | 125 M | 126 M | 126 M | 126 M | 126 M | 126 M | 112 M | 115 M | 112 M | 112 M | - | 112 M | 111 M | 111 M | 111 M | 111 M | 111 M | 111 M | 110 M | 111 M | 110 M | 110 M | 110 M | 110 M | 110 M | 109 M | 112 M | 109 M | 109 M | 110 M | - | 113 M | 113 M | 113 M | 112 M | 113 M | 113 M | 113 M | 113 M | 112 M | 112 M | 113 M | 115 M | 114 M | 114 M | 113 M | 116 M | 113 M | 112 M | 114 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 126 M | 109 M | 115 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
66.6 M | $ 8.92 | 0.56 % | $ 594 M | USA |
 |
Brainsway Ltd.
BWAY
|
31.2 M | $ 13.76 | 0.81 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 26.01 | 0.68 % | $ 722 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
390 M | $ 68.2 | 2.8 % | $ 26.6 B | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 154.35 | 1.57 % | $ 7.65 B | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 17.52 | 1.18 % | $ 934 M | USA |
 |
Guardant Health
GH
|
125 M | $ 87.53 | 0.4 % | $ 11 B | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | $ 103.87 | 0.01 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 15.53 | 3.88 % | $ 470 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
130 M | $ 17.01 | -1.62 % | $ 2.21 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 99.43 | 1.86 % | $ 8.2 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
32.5 K | $ 2.9 | 2.11 % | $ 94.1 K | USA |
 |
IQVIA Holdings
IQV
|
172 M | $ 168.32 | 2.14 % | $ 28.9 B | USA |
 |
Danaher Corporation
DHR
|
713 M | $ 194.97 | 1.87 % | $ 139 B | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
159 M | $ 121.42 | 1.79 % | $ 19.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 199.2 | 0.13 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
223 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
304 M | $ 113.43 | 1.43 % | $ 34.5 B | USA |
 |
BioNano Genomics
BNGO
|
1.27 M | $ 1.12 | 0.66 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
28.4 M | $ 9.28 | 10.24 % | $ 263 M | Israel |
 |
NeoGenomics
NEO
|
128 M | $ 8.36 | 1.46 % | $ 1.07 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.24 | 1.43 % | $ 2 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 78.46 | -0.05 % | $ 5.3 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.41 | 3.31 % | $ 423 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 452.71 | -0.21 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 215.3 | 1.35 % | $ 25 B |  Schweiz |
 |
Celcuity
CELC
|
39.4 M | $ 114.14 | -0.66 % | $ 4.5 B | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.95 | 3.16 % | $ 402 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
98.4 M | $ 199.43 | 0.89 % | $ 19.6 B | USA |
 |
OPKO Health
OPK
|
694 M | $ 1.2 | 0.42 % | $ 833 M | USA |